Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)
Status:
Not yet recruiting
Trial end date:
2027-12-01
Target enrollment:
Participant gender:
Summary
Randomised, double-blind, placebo-controlled clinical trial to evaluate the efficacy of
intravenous metoprolol in patients with Acute Respiratory Respiratory Distress Syndrome
(ARDS).